Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

Ertapenem-Resistant Enterobacteriaceae Risk Factors for Acquisition and Outcomes

(2010) E. P. Hyle et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum- -lactamase-producing Gram-negative organisms

(2010) R. Bazaz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fighting bacterial resistance at the root: need for adapted EMEA guidelines

(2010) Antoine Andremont et al.   LANCET INFECTIOUS DISEASES

Hospital-Acquired Infections Due to Gram-Negative Bacteria

(2010) Anton Y. Peleg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Ertapenem Resistance among Extended-Spectrum- -Lactamase-Producing Klebsiella pneumoniae Isolates

(2009) A. Leavitt et al.   JOURNAL OF CLINICAL MICROBIOLOGY

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Efficacy of Ertapenem for Consolidation Therapy of Extended-Spectrum β-lactamase-Producing Gram-Negative Infections: A Case Series Report

(2008) Melody L Berg et al.   ANNALS OF PHARMACOTHERAPY

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES